COMMUNIQUÉS West-GlobeNewswire

RTI Surgical® Schedules Second Quarter 2019 Earnings Call for August 1, 2019
18/07/2019
DEERFIELD, Ill., July 18, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the second quarter 2019 on [...]
Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies
18/07/2019
CRESTWOOD, Ky. and WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Arvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimer's Association International Conference
18/07/2019
In a preclinical tauopathy model, a tau-targeted PROTAC® protein degrader crosses the blood brain barrier and removes more than 95% of pathologic tau NEW HAVEN, Conn., July 18, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. ( [...]
NeuroMetrix Reports Q2 2019 Financial Results
18/07/2019
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019. The Company develops and markets novel therapies [...]
Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Disorder
18/07/2019
- First head-to-head, randomized controlled trial of its kind comparing Deep TMS, TMS and medication in depression patients published in July issue of the Journal of Psychiatric Research - JERUSALEM, Israel and [...]
Kane Biotech Announces Exclusive Distribution Agreement with Eetoys Pet Products Limited
18/07/2019
WINNIPEG, Manitoba, July 18, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Teleflex Announces Second Quarter 2019 Earnings Conference Call Information
18/07/2019
Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, August 1, 2019 WAYNE, Pa., July 18, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2019 [...]
Emergent BioSolutions to Release Second Quarter 2019 Financial Results and Conduct a Conference Call on August 1, 2019
18/07/2019
GAITHERSBURG, Md., July 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, August 1, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
HEXO Corp Chief Brand Officer Adam Miron steps down from position, stays on as key Board member
18/07/2019
GATINEAU, Quebec, July 18, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) announces that HEXO co-founder, Adam Miron, has decided to step down from his position as Chief Brand [...]
Adam Miron se retire de ses fonctions de directeur de la promotion de l’image de marque de HEXO Corp; demeure un membre clé du conseil d’administration
18/07/2019
GATINEAU, Québec, 18 juill. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO; NYSE: HEXO) annonce que Adam Miron, cofondateur de HEXO, a pris la décision de démissionner de son poste de [...]
Tetra Bio-Pharma’s Management Post Financing Corporate Update
18/07/2019
Drug portfolio with U.S. granted patent protection for ophthalmic use, drug solubility and abuse deterrence; U.S. FDA provides positive response on painful dry eye development program; Panag completes a Phase 3 clinical [...]
UK Confirms its Leadership Position in Advanced Therapies
18/07/2019
UK Confirms its Leadership Position in Advanced Therapies Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration New [...]
Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report
18/07/2019
AMF REGULATED INFORMATION Montrouge, France, July 18, 2019 Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq [...]
Avenant et Bilan semestriel du contrat de liquidité DBV Technologies avec NATIXIS ODDO BHF
18/07/2019
Informations Réglementées Montrouge, France, le 18 juillet (7h30 CET), 2019 Avenant et Bilan semestriel du contrat de liquidité DBV Technologies avec NATIXIS ODDO BHF DBV Technologies (Euronext : DBV – ISIN : [...]
Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased
18/07/2019
Continuing operations[1] net sales up 8% (cc[2], +4% USD) driven by: Cosentyx at USD 858 million, +25% (cc) mainly driven by continued strong US growth (+31%) Entresto grew to USD 421 million, +81% (cc) with increased [...]
Novartis au 2e trimestre: fortes ventes, croissance à deux chiffres du résultat opérationnel core et lancements de Zolgensma et de Piqray; prévision des ventes et du résultat revue à la hausse
18/07/2019
Chiffre d'affaires net des activités poursuivies[1] en hausse de 8% (tcc[2], +4% USD) soutenu par: Cosentyx : USD 858 millions, +25% (tcc) stimulé principalement par le maintien de la forte croissance aux Etats-Unis (+ [...]
Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in Amyotrophic Lateral Sclerosis
18/07/2019
Orphazyme A/S Company announcement No. 17/2019 Company Registration No. 32266355 • Headline results from full analysis expected in H1 2021 Copenhagen, Denmark, July 18, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a [...]
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
18/07/2019
Geneva, Switzerland and Boston, MA – July 18, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for [...]
Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patients
18/07/2019
Data confirm better than expected interim six-month results The system is sustainably well tolerated while preserving residual peripheral vision Some patients improve their ability to identify letters and sequence of [...]

Pages